Renin angiotensin system and its role in biomarkers and treatment in gliomas Alexander Perdomo-PantojaSonia Iliana Mejía-PérezTalia Wegman-Ostrosky Topic Review 16 February 2018 Pages: 1 - 15
Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis Jerry DongDebra SaundersHong Chen Laboratory Investigation 22 January 2018 Pages: 17 - 27
C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin Prit Benny MalgulwarAruna NambirajanMehar Chand Sharma Laboratory Investigation 22 January 2018 Pages: 29 - 39
Genomic analysis of synchronous intracranial meningiomas with different histological grades Tamrin ChowdhuryYongjin YooJi Yeoun Lee Laboratory Investigation 08 February 2018 Pages: 41 - 48
High expression of cystine–glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma Mai Froberg SørensenSólborg Berglind HeimisdóttirChristoph Patrick Beier Laboratory Investigation 05 February 2018 Pages: 49 - 53
Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors Go Hun SeoJin-Ho ChoiHan-Wook Yoo Clinical Study 19 January 2018 Pages: 55 - 62
Prediction of progression in skull base meningiomas: additional benefits of apparent diffusion coefficient value Ching-Chung KoSher-Wei LimYow-Ling Shiue Clinical Study 20 January 2018 Pages: 63 - 71
Efficacy, safety and outcome of frameless image-guided robotic radiosurgery for brain metastases after whole brain radiotherapy Laura-Nanna LohkampPeter VajkoczyMarkus Kufeld Clinical Study 29 January 2018 Pages: 73 - 81
Pediatric neuro-oncology survival disparities in California Tabitha CooneyPaul G. FisherSonia Partap Clinical Study 07 February 2018 Pages: 83 - 97
The predictive potential of hyponatremia for glioblastoma patient survival Oliver D. MrowczynskiAlexandre J. BourcierElias B. Rizk Clinical Study 25 January 2018 Pages: 99 - 104
Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma Jiayi HuangJian L. CampianAlbert H. Kim Clinical Study 27 January 2018 Pages: 105 - 111
The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study Ming ChenShi-hao ZhengShi-ting Li Clinical Study 31 January 2018 Pages: 113 - 122
Surgical treatment of glioblastoma in the elderly: the impact of complications Michael KarsyNam YoonSarah T. Menacho Clinical Study 01 February 2018 Pages: 123 - 132
Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy M. KerkhofI. GaneffM. J. Vos Clinical Study Open access 01 February 2018 Pages: 133 - 139
Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy Charlotte BronnimannCristina IzquierdoFrançois Ducray Clinical Study 31 January 2018 Pages: 141 - 145
End-of-life care of children with diffuse intrinsic pontine glioma Fyeza HasanKevin WeingartenUte Bartels Clinical Study 03 February 2018 Pages: 147 - 153
Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma William C. JacksonChristina I. TsienMichelle M. Kim Clinical Study 01 February 2018 Pages: 155 - 162
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma? Caroline HappoldThierry GorliaFor the EORTC Brain Tumor Group and on behalf of the CENTRIC and CORE Clinical Trial Groups Clinical Study 08 February 2018 Pages: 163 - 171
Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study Connor J. KinslowSamuel S. BruceTony J. C. Wang Clinical Study 09 February 2018 Pages: 173 - 182
Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors Shiyang WangBenjamin LiechtyMatthias A. Karajannis Clinical Study 09 February 2018 Pages: 183 - 190
Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM) Anna NiwińskaKatarzyna PogodaAgnieszka Jagiełło-Gruszfeld Clinical Study 12 February 2018 Pages: 191 - 198
Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors Nathan J. RobisonKee Kiat YeoGirish Dhall Clinical Study 09 February 2018 Pages: 199 - 207
Factors affecting early versus late remission in acromegaly following stereotactic radiosurgery Mohana Rao PatibandlaZhiyuan XuJason P. Sheehan Clinical Study 07 February 2018 Pages: 209 - 216
Letter to the editor: local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit Alexandre RouxMarc ZanelloJohan Pallud Letter to the Editor 20 January 2018 Pages: 217 - 218
Is there a role of breast pathologist in diagnostic challenges of discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis? Kadri Altundag Letter to the Editor 31 January 2018 Pages: 219 - 219